United States · FDA National Drug Code directory

Duloxetine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
25000-609_c8aa863f-eb1f-4b66-9ec6-2af2c7958248
Product NDC
25000-609
Form
CAPSULE, DELAYED RELEASE
Composition / generic term
Duloxetine Hydrochloride
Labeler
MARKSANS PHARMA LIMITED
Marketing category
ANDA
Marketing start / end (source format)
20220527
Source listing expiry
20261231

Source-listed ingredients

  • DULOXETINE HYDROCHLORIDE — 30 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (25000-609-03) · 25000-609-03
  • 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (25000-609-07) · 25000-609-07

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →